CRISPR Therapeutics AG (CRSP) vs Merit Medical Systems, Inc. (MMSI)

A side-by-side comparison of CRISPR Therapeutics AG and Merit Medical Systems, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 2, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — CRSP vs MMSI

growth of $100 · dividends reinvested · last 10y
CRSP +293.5% (+14.7%/yr)MMSI +244.9% (+13.2%/yr)CRSP compounded faster over this window
05001k2kStart $10020182020202220242026$393$345
CRSP MMSI

CRSP vs MMSI: by the numbers

  • •CRSP is the larger company ($5.33B vs $5.10B market cap).
  • •MMSI is profitable (9.22% net margin) while CRSP runs a net loss (-3368.72%).
  • •CRSP grew revenue faster over the past five years (37.32% vs 8.90% CAGR).

Metrics side by side

Valuation

MetricCRSPMMSI
P/E ratioN/A35.27
Forward P/EN/A19.83
P/S ratio397.983.23
P/B ratio3.053.03
EV / EBITDAN/A16.21
FCF yieldN/A3.99%

Profitability

MetricCRSPMMSI
Gross margin-6537.01%49.52%
Operating margin-16191.40%12.75%
Net margin-3368.72%9.22%
ROE-25.83%8.67%
ROIC-21.12%5.80%

Growth (annualized)

MetricCRSPMMSI
Revenue CAGR (5Y)37.32%8.90%
FCF CAGR (5Y)N/A8.96%
Total return CAGR (5Y)-13.01%3.51%

Frequently asked

Which has grown faster, CRSP or MMSI?
Over the past five years, CRSP grew revenue faster — CRSP at a 37.32% CAGR versus MMSI at 8.90%.
Is CRSP or MMSI more profitable?
MMSI runs the higher net margin — CRSP at -3368.72% versus MMSI at 9.22%.
How have CRSP and MMSI total returns compared?
Over the past 5 years, CRSP delivered -13.01% and MMSI delivered 3.51% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 2, 2026.